Elekta to Present Fiscal Year 2024/25 Developments

Elekta AB ( ($SE:EKTA.B) ) just unveiled an announcement.

Elekta has announced a presentation for its fiscal year 2024/25, scheduled for May 28, where the company’s Acting President and CEO, Jonas Bolander, along with CFO Tobias Hägglöv, will discuss the company’s development. The event, which includes a live webcast and Q&A session, reflects Elekta’s commitment to transparency and engagement with analysts and investors, potentially impacting its market positioning and stakeholder relations.

The most recent analyst rating on ($SE:EKTA.B) stock is a Sell with a SEK67.00 price target. To see the full list of analyst forecasts on Elekta AB stock, see the SE:EKTA.B Stock Forecast page.

More about Elekta AB

Elekta is a leader in precision radiation therapy, dedicated to providing access to top-tier cancer care. The company collaborates with customers to develop sustainable, outcome-driven, and cost-efficient solutions, aiming to improve patient lives and offer hope to those affected by cancer. Headquartered in Stockholm, Sweden, Elekta operates in over 40 countries and is listed on Nasdaq Stockholm.

Average Trading Volume: 1,358,834

Current Market Cap: SEK19.09B

Find detailed analytics on EKTA.B stock on TipRanks’ Stock Analysis page.